The various types of chemiluminescent and bioluminescent reactions are described. Applications of luminescence in the analysis of substances of clinical interest are surveyed. The advantages, disadvantages, and prospects for luminescent assays are discussed.
to reduce the quantities of specimen and reagent required in the initial enzymatic step, thus reducing the cost of the assay. The second major application of luminescence is the utilization of luminescent molecules as replacements for radioactive labels in immunoassay.
An important feature of luminescence as an analytical technique is that its usefulness is not confined to clinical chemistry. During the next few years we believe it will find an increasing role in other pathology disciplines, e.g., hematology, immunology, bacteriology, and pharmacology.
Terminology and Definitions
Chemiluminescence may be simply defined as the chemical production of light. In the literature it is often confused with fluorescence.
The difference between these two processes is the source of the energy that is producing molecules in an excited state. In chemiluminescence this is the energy of a chemical reaction, and the decay from the excited state back to the ground state is accompanied by emission of light (luminescence).
In contrast, incident radiation is the source of the energy that, in fluorescence, promotes molecules to an excited state. Analytically, the types of luminescence that have engendered the most interest are chemiluminescence and bioluminescence.
The latter is the name given to a special form of chemiluminescence found in biological systems, in which a catalytic protein increases the efficiency of the luminescent reaction. Indeed, in certain cases the reaction is impossible without a protein component.
Historical Aspects
Luminescence of various types has almost certainly been known to man since ancient times. For example, Aristotle (384-322 B.C.) described the BL1 of dead fish (bacteria) and fungi in his De Anima. After Robert Boyle's discovery that oxygen was intimately involved, little further progress was made in studies of BL until the nineteenth century with the pioneering work of Dubois (1) on the BL of firefly and clam extracts. In contrast to BL, the history of CL, especially that in the aqueous phase, is remarkably short. The fortuitous discovery of lophine (2) and pyrogallol (3) were the first examples in solution. The important CL substances, luminol and lucigenin, were discovered in 1928 (4) and 1935 (5), respectively. For a more complete discussion of luminescence, or indeed of any facet of its history, the reader is referred to the remarkable book by E. N. Harvey (6).
Advantages and Disadvantages of Luminescence and Luminescent Assays
Sensitivity.
Of the several advantages of luminescent methods over their conventional counterparts, their extreme sensitivity is the most important. For example, as compared with spectrophotometry, the BL assay of NADH is estimated to be some 25 000-fold more sensitive (7), and BL assays for glucose and alcohol are, respectively, 55-and 10-fold more sensitive than conventional assays (8). The minimal detectable concentration for an assay ultimately depends on how sensitively light can be detected, and on the quantum efficiency2 () of the reaction. Generally BL reactions are much more efficient than CL reactions; typical quantum efficiencies are in the ranges 0.1-0.8 and 0.01-0.05, respectively. Detection limits for the luminescent assay of ATP, NADH, and H202 are reported to be 10b0 mol (7), 1016 mol (7), and i0 mol/L (9-11).
Range of linear response.
Since CL is an emission process (as opposed to absorption), response is usually linearly proportional to concentration from the minimal detectable concentration up to the point where it is no longer possible to maintain an excess of other reactants relative to the analyte. In the case of ATP assay by the firefly reaction, response is linear over six orders of magnitude (12).
Speed of analysis.
This largely depends on the type of luminescent reaction. In some instances a rapid flash is obtained (<1 s), the peak height of which may be related to analyte concentration; in other cases a more protracted glow occurs with a time course lasting several minutes.
In the latter case the integral or partial integral of the light-time curve has been used as a measure of analyte concentration because it is much less sensitive to mixing efficiency, but this drastically reduces the through-put and speed of analysis. Cost. The major cost benefit of luminescent assays arises from their extreme sensitivity, which allows assays to be performed with much less reagents, hence reducing the cost per test. For example, luminescence offers a means of reducing the cost of cholesterol assays involving cholesterol oxidase (EC 1.1.3.6), because the sensitivity of CL detection of peroxide allows the initial peroxide-producing reaction involving cholesterol oxidase to be scaled down.
Specificity.
Specificity is conferred on BL and CL by using the luminescence as an indicator reaction coupled to intermediates (such as ATP, NADH, and H202) produced enzymatically.
Generally, BL reactions are specific because they are enzymic processes, but CL reactions are nonspecific. Luminol, for example, will undergo a CL reaction with various oxidants (oxygen, peroxide, superoxide, iodine) and its reactions are subject to interferences by reducing agents such as uric acid.
Mechanisms.
A disadvantage of both CL arid BL systems is that in many instances the reaction mechanism is incompletely understood.
Thus, it is particularly difficult to control such reactions when they are used in analysis and to predict or explain analytical interferences. Toxicity and stability. CL and ilL reagents present no known hazard to the environment.
CL reagents (e.g., luminol) are stable and have been used as non-toxic, stable alternatives to radio and enzyme labels in immunoassay.
BL reagents such as luciferase suffer from the same stability problems as many other enzymes. 
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the protein in the presence of Ca2+ to oxyluciferin, with production of light. The spent photoprotein is termed "bluefluorescent protein" (BFP) (87, 88). Specificity. Metal ions other than Ca2 trigger the BL
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The For example, the enzymic generation of peroxide from glucose by glucose oxidase (EC 1.1.3.4) has been coupled to the CL of luminol (9, 122) and the method has been automated by using immobilized enzymes (130). Table 5 ). The luminescent activity of a luminol-IgG conjugate reportedly is unaffected when bound to an antibody (143). In contrast, the luminescent activity of an isoluminol-biotin conjugate increases 10-fold when bound to avidin, a binding protein specific for biotin. This enhancement in light output has been ascribed to increased CL efficiency mediated by the protein (144 benefit may accrue from the monitoring of EMIT6 by using the NADH-dependent bacterial luminescence system, because in many cases the enzyme label used is an oxidoreductase.
Most of the reports of luminescent immunoassays are preliminary in nature, and as yet their sensitivity as compared with radioimmunoassays has not been fully evaluated. A single rod was used for over 100 consecutive analyses of NADH without apparent loss of activity.
Immobilized Luminescent Reagents
Firefly luciferase has also been immobilized chemically onto glass beads, but the bound enzyme retained only 0.07-0.16% of its original activity. The pH optimum of the immobilized enzyme is lower than that' of the native enzyme and it emits light with a major peak at 615 nm, as compared with 562 nm for the native enzyme. An assay for ATP in which immobilized 
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Luminescent Reagents
A factor presently hampering the exploitation of luminescent assays is the quality and availability of CL and BL reagents such as luminol and firefly and marine luciferases. CL reagents such as luminol and lucigenin are widely available, but often of doubtful purity. 129. Neufeld, H. A., Conklin, C. J., and Towner, R. D., Chemiluminescence of luminol in the presence of hematin compounds.
